Clincosm LogoSign in Get a demo

Ovarian Functions in Flight Attendants

Sponsor
Acibadem Fulya Hastanesi (Other)
Overall Status
Unknown status
CT.gov ID
NCT03809338
Collaborator
(none)
300
Enrollment
1
Location
13
Anticipated Duration (Months)
23
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study was to evaluate the effects of night sleep disorder and sleeplessness, excessive hours spent on flight and UV radiation exposure over ovarian function in flight attendant women.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: amh test

Detailed Description

The aim of this study was to evaluate the effects of night sleep disorder and sleeplessness, excessive hours spent on flight and UV radiation exposure over ovarian function in flight attendant women.

On the third day of the menstrual period, evaluate the number of antral follicle count will be examined and the level of hormones showing the ovarian functions will be measured in the blood sample given by the participant.

Study Design

Study Type:
Observational
Anticipated Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Evaluation of Antral Follicle Count and Amh Values in Women Working at Night and Flight Attendants
Actual Study Start Date :
Mar 1, 2019
Anticipated Primary Completion Date :
Mar 1, 2020
Anticipated Study Completion Date :
Apr 1, 2020

Arms and Interventions

Arm Intervention/Treatment
flight attendant women

Assesment antral follicle count on day 3 5ml blood sample to be taken

Diagnostic Test: amh test
Antral follicle count with ultrasound on the 3rd day of menstruation
Other Names:
  • Day 3 antral follicle with transvaginal ultrasonography

    		•
    day working women

    Assesment antral follicle count on day 3 5ml blood sample to be taken

    Diagnostic Test: amh test
    Antral follicle count with ultrasound on the 3rd day of menstruation
    Other Names:
  • Day 3 antral follicle with transvaginal ultrasonography

    		•

    Outcome Measures

    Primary Outcome Measures

    1. level of amh [one year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 35 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • day working women , 25-35 years old

    • night working women , 25-35 years old

    • flight attendant women, 25-35 years old

    Exclusion Criteria:
    • those who cannot enter the groups above

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Acibadem Fulya Hospital Istanbul Turkey

    Sponsors and Collaborators

    • Acibadem Fulya Hastanesi

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Acibadem Fulya Hastanesi
    ClinicalTrials.gov Identifier:
    NCT03809338
    Other Study ID Numbers:
    • AcibademFulyaH
    First Posted:
    Jan 18, 2019
    Last Update Posted:
    Aug 19, 2019
    Last Verified:
    Aug 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 19, 2019